| Autor: |
Pelzer N; 1 Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands., Blom DE; 1 Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands., Stam AH; 1 Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands., Vijfhuizen LS; 2 Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands., Hageman A; 3 Department of Neurology, Rijnstate Hospital, Arnhem, the Netherlands., van Vliet JA; 4 Department of Neurology, Slingeland Hospital, Doetinchem, the Netherlands., Ferrari MD; 1 Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands., van den Maagdenberg A; 1 Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.; 2 Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands., Haan J; 1 Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.; 5 Department of Neurology, Alrijne Hospital, Leiderdorp, the Netherlands., Terwindt GM; 1 Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands. |
| Abstrakt: |
Background Familial hemiplegic migraine (FHM) is a rare monogenic migraine subtype characterised by attacks associated with transient motor weakness. Clinical information is mainly based on reports of small families with only short follow-up. Here, we document a prospective 15-year follow-up of an extended family with FHM type 2. Patients and methods After diagnosing FHM in a patient with severe attacks associated with coma and fever, we identified eight more family members with FHM and one with possible FHM. All family members were prospectively followed for 15 years. In total 13 clinically affected and 21 clinically non-affected family members were genetically tested and repeatedly investigated. Results A novel p.Arg348Pro ATP1A2 mutation was found in 14 family members: 12 with clinical FHM, one with psychomotor retardation and possible FHM, and one without FHM features. In 9/12 (75%) family members with genetically confirmed FHM, attacks were severe, long-lasting, and often associated with impaired consciousness and fever. Such attacks were frequently misdiagnosed and treated as viral meningitis or stroke. Epilepsy was reported in three family members with FHM and in the one with psychomotor retardation and possible FHM. Ataxia was not observed. Conclusion FHM should be considered in patients with recurrent coma and fever. |
